Jefferies reiterates Sotera Health stock buy rating at $20 target
Jefferies maintained a Buy rating on Sotera Health (NASDAQ:SHC) with a $20 target, citing CEO Alton Shader's presentation. The company reported Q3 2026 earnings of $0.29 per share, beating estimates, with revenue at $324.89M. Sotera Health has a 54.6% gross margin and a 3.13 current ratio, and plans growth through cash flow deployment. The stock is undervalued with a PEG ratio of 0.13, according to InvestingPro.


